Joris Vermassen

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 151 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU

Jan Gunst, Yves Debaveye, Fabián Güiza et al. · New England Journal of Medicine · 2023 · 148 citations · Full text

Medicine, Pharmacotherapy, Clinical Nutrition +16

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 137 citations · Full text

Medicine, Critical Care Nursing, Critical Care Medicine +6

Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study

John G. Laffey, Fabiana Madotto, Giacomo Bellani et al. · The Lancet Respiratory Medicine · 2017 · 126 citations · Full text

Medicine, Health Sciences, Cost-effectiveness Analysis +11

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Yaseen M. Arabi, Anthony Gordon, Lennie Derde et al. · Intensive Care Medicine · 2021 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9